Cryptocaryone Promotes ROS-Dependent Antiproliferation and Apoptosis in Ovarian Cancer Cells

Area of Science:

• Natural Products Chemistry
• Molecular Biology
• Cancer Research

Background:

• Cryptocaryone (CPC), a dihydrochalcone from *Cryptocarya* plants, has limited reported antiproliferation activity, particularly against ovarian cancer (OVCA).
• Understanding CPC's mechanism against OVCA is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To investigate the antiproliferative effects and underlying mechanisms of CPC on three distinct human ovarian cancer cell lines (SKOV3, TOV-21G, TOV-112D).
• To elucidate the role of oxidative stress in CPC-induced cellular responses.

Main Methods:

• Cell viability was assessed using MTS assays to determine IC50 values.
• Reactive oxygen species (ROS) generation, mitochondrial dysfunction, and apoptosis were evaluated through various assays.
• DNA damage was quantified by measuring γH2AX expression and 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels.
• The role of oxidative stress was confirmed using N-acetylcysteine (NAC).

Main Results:

• CPC exhibited significant antiproliferative effects against OVCA cells, with varying sensitivities observed across cell lines.
• CPC treatment led to increased ROS production, mitochondrial membrane potential dysfunction, and apoptosis induction.
• CPC significantly induced DNA damage, evidenced by elevated γH2AX and 8-OHdG.
• The observed biological effects were confirmed to be dependent on oxidative stress.

Conclusions:

• Cryptocaryone possesses potent anti-OVCA properties mediated by oxidative stress.
• CPC induces apoptosis and DNA damage in ovarian cancer cells.
• CPC represents a promising natural product for further investigation as an anti-ovarian cancer agent.